Enzymotec Ltd. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
Enzymotec Ltd. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value of $3.06 million as of 2016-12-31, per its 20-F filed 2017-03-16.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 · last filed 2017-03-16
- 2016-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $3.06M.
- 2015-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $6.01M.
- 2014-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $4.96M.
- 2013-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $43.20M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value |
|---|---|
| 2016-12-31 | $3.06M 20-F · filed 2017-03-16 |
| 2015-12-31 | $6.01M 20-F · filed 2016-03-03 |
| 2014-12-31 | $4.96M 20-F · filed 2015-03-02 |
| 2013-12-31 | $43.20M 20-F/A · filed 2014-02-18 |